Found: 7 articles
Article | Edition |
---|---|
D.V. Nebieridze, N.M. Akhmedzhanov, A.S. Safaryan
Current management strategy for high-risk hypertensive patients – focus on lipid-lowering therapy
|
№9 / 2019 |
M.V. Ezhov
EVOLOUCUMAB - NEW HYPOLIDEPHEMIC AGENT FOR CARDIOVASCULAR RISK REDUCTION
|
№20 / 2017 |
M.V. Ezhov, E.V. Sorokin
SAFETY AND EFFICACY OF LONG-TERM THERAPY WITH HIGH DOSES OF ATORVASTATIN
|
№15 / 2017 |
T.A. Rozhkova, V.I. Kaminnaya, M.Yu. Zubareva
THE USE OF ROSUVASTATIN IN PATIENTS WITH HYPERCHOLESTEROLEMIA (IIA AND IIB TYPE HYPERLIPDEMIA, FAMILIAL HYPERCHOLESTERINEMIA) IN CLINICAL OUTPATIENT PRACTICE
|
№10 / 2017 |
A.M. Shilov, O.A. Zorina, N.B. Petrukhina
INTESTINAL DYSBIOSIS, PERIODONTITIS AND METABOLIC-ASSOCIATED CARDIOVASCULAR DISEASES
|
№14 / 2013 |
L.O. Minushkina
Simvastatin In The Treatment Of Atherosclerosis
|
№8 / 2009 |
A.M. Shilov, A. Sh. Avshalumov, V.B. Markovskiy, E.N. Sinitsyna, E.G. Tanaeva, R.U. Baltaeva
Tactics Of Dyslipidemias Treatment In Metabolic Syndrome: Statins Or Fibrates?
|
№6 / 2009 |